<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03563378</url>
  </required_header>
  <id_info>
    <org_study_id>2017-162</org_study_id>
    <nct_id>NCT03563378</nct_id>
  </id_info>
  <brief_title>Effects of Intraoperative Normal Saline vs Lactated Ringer on Outcomes in Pediatric Liver Transplantation</brief_title>
  <official_title>Effects of Intraoperative Normal Saline vs Lactated Ringer on Outcomes in Pediatric Liver Transplantation: A Double-blind Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lactated Ringer(LR) has been extensively used to maintain and replace intravascular volume in
      a variety of anesthetic procedures. However, the utility of LR in pediatric with hepatic
      failure undergoing liver transplantation is unclear, because addition of exogenous lactate
      may increase lactate concentration. In addition,large amounts of normal saline(NS) which does
      not contain lactate can induce a hyperchloremic metabolic acidosis and have been asociated
      with adverse effects on kidney injury, coagulation, and death. Accordingly, the investigators
      performed a double-blinded randomized trial comparing the effects of intraoperative NS or LR
      on outcomes in pediatric receiving Liver transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Anticipated">July 28, 2018</start_date>
  <completion_date type="Anticipated">May 27, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 27, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in lactate level of the lactated ringer group compared to the normal saline group</measure>
    <time_frame>up to 3 days after surgery</time_frame>
    <description>Baseline serum lactate will be measured after randomization and again after surgery, then every 24 hours for 72 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of mechanical ventilation</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Length of mechanical ventilation in ICU measured in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Days spend in ICU within 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day mortality</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Patient mortality during the first 30 days after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Biliary Atresia Intrahepatic Syndromic Form</condition>
  <arm_group>
    <arm_group_label>Lactated ringers solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive Lactated Ringer's solution during the intraoperative period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive Normal saline solution during the intraoperative period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactated Ringer</intervention_name>
    <description>Patients will be administered Lactated Ringer's solution for intraoperative fluid management.</description>
    <arm_group_label>Lactated ringers solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Patients will be administered normal saline for intraoperative fluid management.</description>
    <arm_group_label>Normal saline solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Criteria

        Inclusion Criteria:

          1. Pediatric patients between the age of 3 month and 6 years

          2. Scheduled for living donor liver transplantation

        Exclusion Criteria:

          1. Re-transplantation

          2. Combined liver and kidney transplantation

          3. Congenital heart disease

          4. Refused to participate the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>qi lu, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>diansan su, Dr.</last_name>
    <phone>+862168383702</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>diansan su, Dr.</last_name>
      <phone>+862168383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2018</study_first_posted>
  <last_update_submitted>June 19, 2018</last_update_submitted>
  <last_update_submitted_qc>June 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

